Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial

Author:

Hasegawa Yasuhisa1ORCID,Tsukahara Kiyoaki2,Yoshimoto Seiichi3ORCID,Miura Kouki4,Yokoyama Junkichi5,Hirano Shigeru6,Uemura Hirokazu7ORCID,Sugasawa Masashi8,Yoshizaki Tomokazu9,Homma Akihiro10,Chikamatsu Kazuaki11,Suzuki Mikio12ORCID,Shiotani Akihiro13,Matsuzuka Takashi114,Kohno Naoyuki15,Miyazaki Masakazu16,Oze Isao17,Matsuo Keitaro17ORCID,Kosuda Shigeru18,Yatabe Yasushi3,

Affiliation:

1. Asahi University Hospital, Gifu, Japan

2. Tokyo Medical University, Tokyo, Japan

3. National Cancer Center Hospital, Tokyo, Japan

4. International University of Health and Welfare, Mita Hospital, Tokyo, Japan

5. Nadogaya Hospital, Kashiwa, Japan

6. Kyoto Prefectural University of Medicine, Kyoto, Japan

7. Nara Medical University, Nara, Japan

8. Saitama Medical University International Medical Center, Hidaka, Japan

9. Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

10. Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

11. Gunma University School of Medicine, Maebashi, Japan

12. University of the Ryukyus Faculty of Medicine, Okinawa, Japan

13. National Defense Medical College, Tokorozawa, Japan

14. Fukushima Medical University, Fukushima, Japan

15. Kyorin University School of Medicine, Mitaka, Japan

16. National Cancer Center Hospital East, Kashiwa, Japan

17. Aichi Cancer Center Research Institute, Nagoya, Japan

18. Kouseikai General Clinic and Hospital, Kawagoe, Japan

Abstract

PURPOSE This study aimed to compare patients with early oral cavity squamous cell carcinoma (OCSCC) (tumor category [T] 1-2, node-negative, and no distant metastasis) treated with traditional elective neck dissection (ND) with those managed by sentinel lymph node biopsy (SLNB) using survival and neck function and complications as end points. METHODS Sixteen institutions in Japan participated in the study (trial registration number: UMIN000006510). Patients of age ≥ 18 years with histologically confirmed, previously untreated OCSCC (Union for International Cancer Control TNM Classification of Malignant Tumors 7th edition T1-2, node-negative no distant metastasis), with ≥ 4 mm (T1) depth of invasion, were randomly assigned to undergo standard selective ND (ND group; n = 137) or SLNB-navigated ND (SLNB group; n = 134). The primary end point was the 3-year overall survival rate, with a 12% noninferiority margin; secondary end points included postoperative neck functionality and complications and 3-year disease-free survival. Sentinel lymph nodes underwent intraoperative multislice frozen section analyses for the diagnosis. Patients with positive sentinel lymph nodes underwent either one-stage or second-look ND. RESULTS Pathologic metastasis-positive nodes were observed in 24.8% (34 of 137) and 33.6% (46 of 134) of patients in the ND and SLNB groups, respectively ( P = .190). The 3-year overall survival in the SLNB group (87.9%; lower limit of one-sided 95% CI, 82.4) was noninferior to that in the ND group (86.6%; lower limit 95% CI, 80.9; P for noninferiority < .001). The 3-year disease-free survival rate was 78.7% (lower limit 95% CI, 72.1) and 81.3% (75.0) in the SLNB and ND groups, respectively ( P for noninferiority < .001). The scores of neck functionality in the SLNB group were significantly better than those in the ND group. CONCLUSION SLNB-navigated ND may replace elective ND without a survival disadvantage and reduce postoperative neck disability in patients with early-stage OCSCC.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3